Arcoma
8.96 SEK
+7.43 %
Less than 1K followers
ARCOMA
First North Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Arcoma
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 31.9 | 36.8 | 156.8 | 34.9 | 31.4 | 29.9 | 34.7 | 130.8 |
| EBITDA | 4.3 | 5.0 | 21.6 | 4.5 | 1.9 | 3.9 | 3.4 | 13.6 |
| EBIT | 2.4 | 3.1 | 13.7 | 2.6 | 0.0 | 2.0 | 1.7 | 6.2 |
| EBIT-% | 7.6 % | 8.4 % | 8.7 % | 7.4 % | 0.1 % | 6.6 % | 4.8 % | 4.8 % |
| Profit before taxes | 2.3 | 3.3 | 13.8 | 2.6 | 0.0 | 2.0 | 1.7 | 6.3 |
| Net income | 2.3 | 0.7 | 11.2 | 2.0 | 1.6 | 1.4 | 5.0 |